14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

CYTR Predictions History

6 years ago
Jay predicted that CYTR for 2017-05-15 is going $0.310 (-87.78%)

Rank:

6 years ago
JS predicted that CYTR for 2017-05-12 is going $0.437 (-82.77%)

6 years ago
IZ predicted that CYTR for 2017-05-12 is going $0.472 (-82.32%)

Rank:

6 years ago
JuanC Villegas predicted that CYTR for 2017-05-12 is going $0.424 (-84.12%)

6 years ago
Will predicted that CYTR for 2017-05-12 is going $0.399 (-85.06%)

Rank:

7 years ago
JS predicted that CYTR for 2017-04-25 is going $0.792 (-84.56%)

7 years ago
Sean predicted that CYTR for 2017-04-25 is going $0.760 (-84.74%)

Rank:

7 years ago
JS predicted that CYTR for 2017-04-24 is going $0.596 (-88.03%)

7 years ago
Fook Mi predicted that CYTR for 2017-04-24 is going $0.600 (-83.69%)

Rank:

7 years ago
Tim.Long.5991 predicted that CYTR for 2017-04-24 is going $1.50 (-59.22%)

Rank:
Click to get the best stock tips daily for free!

About CytRx Corporation

CytRx Corporation, a biopharmaceutical research and development company, focuses on oncology and rare diseases. It engages in the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company's lead candidates include linker activated drug release (LADR) -7, LADR-8, LADR-9, and LADR-10; and A... CYTR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT